Turkish Version of the Cognitive Functioning Self-Assessment Scale
The Validity and Reliability of the Turkish Version of the Cognitive Functioning Self-Assessment Scale
1 other identifier
observational
180
1 country
1
Brief Summary
Self-report scales used in the assessment of cognitive functions can serve as an initial screening tool for the general population, aside from specific neuropsychiatric tests, which are more costly and time-consuming. This study is designed to examine the validity and reliability of the Turkish version of the Cognitive Functioning Self-Assessment Scale (CFSS). Permission for the study has been obtained from the developer of the scale, Dr. Maria Antonietta Annunziata. The Turkish translation of the scale will be made, and approval will be obtained from the original author for the final version. Subsequently, the Turkish version of the CFSS, the Hospital Anxiety and Depression Scale, and the Cognitive Failures Questionnaire will be administered to participants. Surveys will be completed either online via Google Forms or in written form. To assess the reliability of the scale, the Turkish version of the CFSS will be re-administered to the same participants 7-14 days later.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Nov 2024
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
November 5, 2024
CompletedFirst Posted
Study publicly available on registry
November 7, 2024
CompletedStudy Start
First participant enrolled
November 20, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
February 20, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
March 3, 2025
CompletedMarch 10, 2025
March 1, 2025
3 months
November 5, 2024
March 5, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Cognitive Functioning Self-Assessment Scale (Turkish Vesion)
The "Cognitive Functioning Self-Assessment Scale" developed by Annunziata et al. in 2016, consists of 18 questions aimed at assessing cognitive function areas such as attention, memory, problem-solving, temporal-spatial orientation, and dual-task performance. Scoring is done on a 5-point Likert scale, ranging from 1 to 5. Higher scores on the scale indicate an increase in subjective cognitive complaints.
Baseline and 7-14 days after
Hospital Anxiety and Depression Scale (HADS)
The HADS was developed by Zigmond and Snaith in 1983. The HADS consists of a total of 14 items, including 7 items for anxiety and 7 items for depression. The items are scored between 0-3 points on a 4-point Likert-type scale according to how the individual felt in the previous week. The scores that can be obtained from anxiety and depression subscales vary between 0-21. The Turkish validity and reliability study of the scale was conducted by Aydemir et al. in 1997. High scores obtained from the scale indicate increased mood disorder.
Baseline
Cognitive Failures Questionnaire (CFQ)
The BDI is a self-report scale developed by Broadbent et al. in 1982 to assess cognitive failures that occur in daily life. Errors in perception, memory and motor functions are assessed with 25 questions. Each question is scored from 0 (never) to 4 (very often). The total score that can be obtained from the scale ranges from 0-100. Higher scores indicate an increased level of cognitive failure and worse cognitive status. The Turkish validity and reliability study of the scale was conducted by Ekici et al. in 2016.
Baseline
Eligibility Criteria
Healthy individuals over 18 years old
You may qualify if:
- Individuals over 18 years old
You may not qualify if:
- Taking antidepressants
- Having a neurological or psychiatric disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Kutahya Health Sciences University
Kütahya, 43100, Turkey (Türkiye)
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
November 5, 2024
First Posted
November 7, 2024
Study Start
November 20, 2024
Primary Completion
February 20, 2025
Study Completion
March 3, 2025
Last Updated
March 10, 2025
Record last verified: 2025-03